Infrequent Fas Mutations but No Bax or p53 Mutations in Early Mycosis Fungoides: A Possible Mechanism for the Accumulation of Malignant T Lymphocytes in the SkinO. Dereure, Eric C. Vonderheid, Edi Levi et al.|Journal of Investigative Dermatology|2002Cited by 101
Risk of irAEs in patients with autoimmune diseases treated by immune checkpoint inhibitors for stage III or IV melanoma: results from a matched case–control studyLéo Plaçais, Célèste Lebbé, Stéphane Dalle et al.|Annals of the Rheumatic Diseases|2022Cited by 34
Relevance of body mass index as a predictor of systemic therapy outcomes in metastatic melanoma: analysis of the MelBase French cohort data☆Y. Di Filippo, Henri Montaudié, A Stephan et al.|Annals of Oncology|2020Cited by 30
Combined Therapy with Anti-PD1 and BRAF and/or MEK Inhibitor for Advanced Melanoma: A Multicenter Cohort StudySandra Huynh, Julie Delyon, Laurent Mortier et al.|Cancers|2020Cited by 21
Non-V600E/K BRAF Mutations in Metastatic Melanoma: Molecular Description, Frequency, and Effectiveness of Targeted Therapy in a Large National CohortManon Girod, O. Dereure, Stéphane Dalle et al.|JCO Precision Oncology|2022Cited by 14